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Introduction
The homeostasis of proteins in the ER is highly dependent on ef-
fective quality control pathways that recognize and dispose of pro-
teins that are either misfolded or surplus to requirement (Hegde 
and Ploegh, 2010; Brodsky, 2012). The ER-associated degrada-
tion (ERAD) pathway promotes the dislocation of proteins from 
the ER into the cytosol, where they can be degraded by the pro-
teasome. ERAD therefore plays an important role in maintain-
ing homeostasis within the early secretory pathway.
The established requirements for ERAD are the recogni-
tion, ubiquitination, and dislocation of proteins across the ER 
membrane, although mechanistic insight into this process is still 
required (Vashist and Ng, 2004; Carvalho et al., 2006). A core 
component of the cellular ERAD machinery is a membrane-
embedded ER ligase, which, either directly or with the aid of 
luminal adaptors, binds ERAD substrates (Kostova et al., 2007). 
In yeast, two ERAD E3 ligases, Hrd1p and Doa10p, are suffi-
cient to recognize the diverse set of misfolded proteins (Mehnert 
et al., 2010), whereas in mammals, the repertoire of ERAD E3 
ligases has diversified (Li et al., 2008), presumably to cope with 
the higher degree of specialization and regulation required in 
complex multicellular organisms.
Viruses also appropriate cellular ERAD pathways to degrade 
host proteins. Two well-characterized viral gene products from 
human cytomegalovirus, US2 and US11, hijack separate ERAD 
pathways to degrade newly synthesized major histocompatibility 
complex (MHC) class I (MHC-I) molecules (Wiertz et al., 1996a,b; 
The regulated turnover of endoplasmic reticulum (ER)–resident membrane proteins requires their extraction from the membrane lipid bilayer and subsequent 
proteasome-mediated degradation. Cleavage within the 
transmembrane domain provides an attractive mechanism 
to facilitate protein dislocation but has never been shown for 
endogenous substrates. To determine whether intramembrane 
proteolysis, specifically cleavage by the intramembrane-
cleaving aspartyl protease signal peptide peptidase (SPP), 
is involved in this pathway, we generated an SPP-specific 
somatic cell knockout. In a stable isotope labeling by 
amino acids in cell culture–based proteomics screen, we 
identified HO-1 (heme oxygenase-1), the rate-limiting en-
zyme in the degradation of heme to biliverdin, as a novel 
SPP substrate. Intramembrane cleavage by catalytically 
active SPP provided the primary proteolytic step required 
for the extraction and subsequent proteasome-dependent 
degradation of HO-1, an ER-resident tail-anchored protein. 
SPP-mediated proteolysis was not limited to HO-1 but was 
required for the dislocation and degradation of additional 
tail-anchored ER-resident proteins. Our study identifies tail-
anchored proteins as novel SPP substrates and a specific 
requirement for SPP-mediated intramembrane cleavage in 
protein turnover.
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Figure 1. A functional proteomics screen in a SPP somatic cell knockout identifies HO-1 as a potential SPP substrate. (A) Odyssey infrared capture of 
immunoblot for SPP on SPP wild-type (WT, +/+) HCT116, SPP heterozygous (D19 and D12, +/), or SPP knockout (B4 and B6-1, /). (B) Schematic 
of core/E1 hepatitis C polyprotein expressed from a lentivirus, with signal peptidase (SP) and signal peptide peptidase (SPP) cleavage sites (black ar-
rowheads). The site of the F130E mutation within the amphipathic helix of core is noted (gray arrowhead). The immature (iCore) and mature (mCore) core 
products, produced after SP and SPP cleavage, are also shown. sig seq, signal sequence. (C) Immunoblot for core antigen in cells expressing WT or mutant 
(F130E) core in WT (+/+) or SPP knockout (/) cells. (D) Immunoblot for mutant (F130E) core antigen in WT (+/+), SPP knockout (/), or SPP knockout 
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(/) cells transduced with exogenous SPP WT or catalytically inactive SPP D/A mutant, in the presence of mock (top), proteasome (Bortezomib; middle), 
or the SPP-specific (Z-LL)2 ketone (bottom) inhibitors. (E) Schematic of SILAC mass spectrometry procedure. The experiment was performed in forward and 
reverse labeling. k/o, knockout; m/z, mass per charge. (F) Results of RNA-Seq analysis for these proteins are also listed. In the reverse SILAC experiment, 
SPP WT HCT116 cells were cultured in light SILAC media (L), and in the forward experiment, SPP WT HCT116 cells were cultured in heavy SILAC media 
(H). Reported SILAC ratios in the reverse analysis are H/L, i.e., B4 cells/HCT116 WT cells and, in the forward analysis, are 1/(H/L), i.e., 1/(HCT116 
WT cells/B4 cells). Pep represents the unique peptide count. The proteins highlighted in bold type are of type II orientation (either transmembrane or tail 
anchored). SPP-derived peptides were only identified from SPP HCT116 WT cells and not from SPP knockout B4 cells.
 
Lilley and Ploegh, 2005). The study of US2 and US11 has led 
to the identification of novel ERAD components and helped de-
fine the ERAD pathway in mammalian cells (Lilley and Ploegh, 
2005). In a genetic screen, we recently identified TRC8, an ER-
resident, polytopic membrane protein, as the E3 ligase required 
for the US2-mediated ubiquitination and dislocation of MHC-I 
molecules (Stagg et al., 2009). We found that in both the pres-
ence and absence of US2, TRC8 readily associated with the 
intramembrane-cleaving aspartyl protease signal peptide peptidase 
(SPP), an enzyme previously implicated in the US2-mediated 
dislocation of MHC-I (Loureiro et al., 2006). This association 
of SPP with TRC8 was intriguing, not least because of the po-
tential role for intramembrane proteolysis in the cleavage and 
dislocation of membrane proteins en route from the ER to the cyto-
sol. SPP cleaves substrate polypeptides in their transmembrane 
domain (TMD) and has two active site aspartate residues within 
the conserved motifs YD and LGLGD of adjacent membrane-
spanning regions (Lemberg and Martoglio, 2004; Golde et al., 
2009). The orientation of these active sites of SPP within the 
transmembrane regions is inverted relative to the closely related 
presenilin proteases (Weihofen et al., 2002), with the important 
functional consequence that presenilins cleave membrane pro-
teins with a type I orientation, whereas SPP only cleaves mem-
brane proteins with a type II orientation, a conserved feature of 
all known SPP substrates. The best-characterized function of 
SPP is the intramembrane cleavage of signal sequence stubs left 
in the ER membrane after signal peptidase (SP)–mediated pro-
cessing of the precursor protein. Proteolytic cleavage by SPP 
promotes the release of these signal peptide fragments into the 
cytosol. In a similar fashion, SPP is required for maturation of 
the hepatitis C virus core protein (McLauchlan et al., 2002).
While the activity of SPP in liberating signal peptides from 
the ER membrane is well characterized, whether SPP plays a 
significant role in the degradation of endogenous ER proteins is 
unclear. Although SPP-mediated cleavage of an ERAD substrate 
has not been reported, a role for intramembrane proteolysis in 
ER protein degradation is attractive, as cleavage within the plane 
of the membrane will reduce the energy required for dislocation 
and thereby facilitate extraction of the protein from the mem-
brane (Greenblatt et al., 2012). Fragments of ERAD substrates 
have in fact been identified in the cytosol after proteasome in-
hibition (Huppa and Ploegh, 1997; Loo and Clarke, 1998), but 
this is not a general requirement for ERAD, as full-length de-
glycosylated ERAD substrate intermediates, e.g., MHC-I mole-
cules (Blom et al., 2004), can be identified in the cytosol. The 
finding that several critical ERAD components (Derlins, UBAC2, 
and iRhoms) are themselves inactive homologues of the rhomboid 
family of intramembrane-cleaving serine proteases (Greenblatt 
et al., 2011; Zettl et al., 2011; Christianson et al., 2012) lends 
support to the idea that dislocation and proteolysis may share 
common underlying mechanistic features. RHBDL4, an ER-
resident, intramembrane-cleaving, active rhomboid protease, pro-
motes ERAD by cleaving type I transmembrane proteins (TCR-) 
as well as polytopic membrane proteins (mutant opsin and mu-
tant polycystin-1; Fleig et al., 2012). Expression of RHBDL4 
increases with ER stress, which, together with the identification 
of an ubiquitin-interacting motif in the cytosolic tail, supports a 
potential role for RHBDL4 in ERAD, though endogenous ERAD 
substrates have not been identified.
To further investigate the role of intramembrane-cleaving 
proteases, in particular SPP, in the cleavage and dislocation of 
ERAD substrates, we generated a somatic cell knockout of SPP. 
Using a functional proteomics approach, we here identify a critical 
role for SPP in the proteolytic cleavage and subsequent disloca-
tion and degradation of endogenous HO-1 (heme oxygenase-1), 
a tail-anchored ER-resident protein, which is the rate-limiting 
enzyme in the degradation of heme to biliverdin and carbon 
monoxide. This SPP activity is not limited to HO-1 but is required 
for the dislocation and degradation of additional tail-anchored 
ER-resident proteins.
Results
A functional proteomics screen identifies  
a role for SPP in the degradation of the 
tail-anchored protein HO-1
We recently identified TRC8 as the ubiquitin E3 ligase recruited 
by human cytomegalovirus–encoded US2 for the ERAD of 
MHC-I molecules. TRC8 is an ER-resident E3 ligase, which we 
found to associate with the intramembrane-cleaving aspartyl 
protease SPP, suggesting a potential role for this protease in the 
ERAD of client substrate proteins (Stagg et al., 2009). To deter-
mine whether SPP plays a role in the dislocation of proteins 
from the ER membrane into the cytosol, we generated a condi-
tional knockout of SPP in the epithelial colorectal carcinoma 
cell line HCT116. LoxP-flanking sites were engineered into one 
of the two targeting constructs, which allowed for its later re-
moval after introduction of Cre recombinase (Figs. S1 and S2 
and Tables S1–S3).
Targeted deletion of a single SPP allele significantly re-
duced SPP protein levels, as detected by immunoblot analysis 
(Fig. 1 A, clones D19/D12). Subsequent treatment of these cells 
with Cre recombinase successfully deleted the remaining SPP al-
lele, resulting in a complete loss of SPP protein (Fig. 1 A, clones 
B4/B6-1). SPP/ cells appeared healthy but grew slightly slower 
and were less adherent compared with parental cells. To confirm 
that the genetic absence of SPP caused the predicted phenotype, 
we tested whether SPP/ cells cleave and release the hepatitis 
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only two were in a type II membrane orientation required for 
cleavage by SPP; Sec11c (see Fig. 3 B) and heme oxygenase 
(HO-1), the well-characterized rate-limiting enzyme that cata-
lyzes the degradation of heme to biliverdin and carbon monox-
ide (Ryter et al., 2006).
Endogenous HO-1 is degraded in an  
SPP-dependent pathway
To validate the mass spectrometry data, we probed for endogenous 
HO-1 by immunoblot analysis of SPP WT and SPP knockout 
total cell lysates. The HO-1 antibody was insufficiently sensitive 
to visualize basal levels of HO-1 in either WT or SPP knockout 
cells (Fig. 2 A). However, endogenous HO-1 can be induced 
by several physiological stimuli and was readily detected after 
incubation of cells with 50 µM hemin for 15 h (Fig. 2 A). Subse-
quent removal of hemin allowed us to follow the degradation of 
endogenous HO-1 and determine whether SPP was required for 
its degradation. In SPP knockout cells, HO-1 degradation was 
delayed, as compared with WT, best seen at 12 and 24 h after 
hemin induction (Fig. 2 A). This delay in degradation could be 
rescued by exogenous expression of WT SPP (Fig. 2 B), sug-
gesting a role for SPP in HO-1 degradation. Furthermore, the 
catalytically inactive SPP D265A (SPP D/A) mutant had a dominant- 
negative effect and stabilized HO-1 (Fig. 2 B), presumably through 
the formation of inactive enzyme–substrate complexes.
As a result of concerns that the SPP knockout cells had 
compensated for the prolonged absence of SPP, we took an al-
ternative, RNAi-mediated approach to determine whether short-
term depletion of SPP also affected HO-1 degradation. We used 
siRNA to deplete SPP from HeLa cells, induced HO-1 expres-
sion with hemin, and after removal of this stimulus, monitored 
HO-1 degradation over time. The rate of endogenous HO-1 deg-
radation was dramatically reduced in SPP-depleted HeLa cells 
(Fig. 2 C), with an estimated half-life of 10 h from the peak of 
HO-1 induction (Fig. 2 C, bottom). 24 h after removal of hemin, 
HO-1 levels had almost completely degraded in WT cells, with 
little HO-1 degradation from SPP-depleted cells. In conclusion, 
our experiments from both SPP knockout as well as SPP-
depleted cells identify a critical role for SPP in the degradation 
of endogenous HO-1.
SPP-mediated intramembrane cleavage  
is required for HO-1 dislocation  
and degradation
To further determine the cellular requirements for HO-1 degra-
dation, we examined endogenous HO-1 degradation in the HEK-
293T cell line. As seen in HCT116 and HeLa cells, detection of 
endogenous HO-1 in HEK-293T cells required induction with 
hemin (Fig. 3 A). After removal of the hemin stimulus, HO-1 
degradation was inhibited by incubation with either the protea-
some inhibitor lactacystin or the SPP-specific inhibitor (Z-LL)2 
ketone (Fig. 3 A). Overexpression of WT SPP induced the rapid 
degradation of HO-1 (Fig. 3 B), whereas the catalytically inac-
tive (SPP D/A) mutant again showed a dominant-negative effect 
and stabilized HO-1 expression. In contrast, levels of exogenous 
Sec11c were not affected by overexpression of WT SPP (Fig. 3 B). 
Although HO-1 binding to WT SPP was not detected as a result 
C core antigen, a well-established SPP substrate (McLauchlan 
et al., 2002). The hepatitis C polyprotein is cotranslationally in-
serted into the ER membrane. Initial cleavage of the N-terminal 
core antigen (core) by signal peptidase leaves the immature 
core in the ER membrane. Subsequent intramembrane cleav-
age by SPP promotes the release of mature core from the ER mem-
brane, allowing its insertion into lipid droplets via an amphipathic 
helix (Fig. 1 B; Boulant et al., 2006; McLauchlan, 2009). By 
gel electrophoresis, wild-type (WT) core migrated slower in the 
SPP knockout (SPP/) cell line as compared with the WT SPP 
(SPP+/+) parental cell line, consistent with a loss of SPP-mediated 
cleavage (Fig. 1 C, first and second lanes). The difference between 
SPP/ and WT cells was readily detected on examination of a 
mutant hepatitis C virus core, in which a single F130E substi-
tution breaks the amphipathic helix and prevents insertion of 
core into lipid droplets (Boulant et al., 2006). As reported, the 
F130E core was rapidly degraded in WT SPP cells (Fig. 1 C, 
fourth lane). In contrast, the F130E core was stably expressed in 
SPP knockout cells (Fig. 1 C, third lane), presumably because 
it could not be extracted from the ER membrane. Genetic com-
plementation of SPP knockout cells with WT SPP restored nor-
mal function (Fig. 1 D). The F130E hepatitis C core mutant 
was rapidly degraded after reintroduction of WT SPP but not 
the catalytically inactive D265A mutant (D/A; Fig. 1 D, second 
blot, third and fourth lanes, respectively). Degradation of F130E 
core was protected by both proteasome (bortezomib) and SPP-
specific ((Z-LL)2 ketone) inhibitors. As predicted, bortezomib res-
cued a faster migrating, cleaved form of F130E core (Fig. 1 D, 
third blot, first and third lanes), whereas treatment with the SPP 
inhibitor protected the slower migrating, uncleaved F130E core 
band (Fig. 1 D, fourth blot, first and third lanes). We therefore 
conclude that SPP/ cells behave as phenotypic and functional 
SPP knockouts.
We were concerned that the SPP knockout cells may have 
compensated for the complete absence of SPP and up-regulated 
one or more related intramembrane-cleaving proteases. How-
ever, these were not detected by proteomic (Fig. 1 F) or RNA-Seq 
analysis of SPP WT and deficient cells (Table S4). Specifically, 
we found no change in the level of the related ER-resident SPPL3 
nor did we see any change in transcript levels for the related 
proteases SPPL2A, SPPL2B, ADAM10, or DERLIN1. In addi-
tion, the RNA-Seq confirmed the loss of exon 3 of HM13 in the 
knockout cell line (Fig. S3).
To identify potential SPP substrates, we performed a pro-
teomic screen to isolate ER membrane proteins that accumu-
late in SPP knockout cells. The rationale was that SPP substrates 
should accumulate in the ER membrane of SPP knockout cells. 
Using a stable isotope labeling by amino acids in cell culture 
(SILAC)–based functional proteomics technique (Mann, 2006), 
we compared the relative abundance of microsomal proteins 
between SPP WT and SPP knockout cell lines (Fig. 1 E). The 
experiment was performed in forward and reverse conditions, 
swapping the heavy and light isotope label between experiments. 
The validity of this experimental approach was confirmed as 
SPP-derived peptides were identified in the WT but not in the 
SPP knockout cells. (Fig. 1 F). Six membrane proteins were up-
regulated more than twofold in the absence of SPP, of which 
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Selected ER-resident tail-anchored  
proteins are cleaved and degraded in an 
SPP-dependent fashion
To determine whether SPP-mediated cleavage was unique to HO-1 
or required for the degradation of other ER-resident tail-anchored 
of rapid HO-1 degradation, we took advantage of the stabilization 
of HO-1 by the SPP D/A mutant to demonstrate binding of HO-1 
to SPP (Fig. 3 C). Immunoprecipitation of HA–HO-1 allowed 
detection of the SPP D/A mutant (Fig. 3 C, left), and the recipro-
cal pull-down of myc-SPP D/A detected HA–HO-1 (Fig. 3 C, 
middle), confirming the interaction between these proteins.
Having demonstrated a requirement for SPP catalytic ac-
tivity in HO-1 degradation, we wanted to determine whether HO-1 
was itself a direct substrate. To visualize progression of HO-1 deg-
radation, we performed a pulse–chase analysis of [35S]methionine/
cysteine-radiolabeled cells and immunoprecipitated HA-tagged 
HO-1. After overexpression of WT or catalytically inactive SPP 
(SPP D/A), HO-1 can be visualized in both the cleaved and un-
cleaved form (Fig. 4 A). The dominant-negative activity of the 
SPP D/A mutant was confirmed, as it stabilizes uncleaved HO-1, 
detected as a single band (Fig. 4 A, third and fourth lanes). In con-
trast, upon overexpression of WT SPP, HO-1 is already detected 
in a predominantly cleaved form at the 0-h time point, with a very 
faint, more slowly migrating uncleaved form corresponding to 
the single band seen with the SPP D/A mutant (Fig. 4 A, first lane). 
By the 2-h chase point, only the cleaved, faster migrating band 
remains detectable and has lost intensity compared with the 0-h 
time point at the start of the chase (Fig. 4 A, second lane). The 
small change in molecular mass corresponds to the predicted loss 
of an 10–amino acid polypeptide fragment of HO-1 after SPP 
cleavage (Fig. 4 A, compare first and second lanes with third and 
fourth lanes) by WT but not the SPP D/A mutant.
To improve resolution of these subtle changes in band mi-
gration and visualize the proteolytic HO-1 intermediates more 
clearly, a truncation mutant, HO-130–184 (HO-1 short), was 
generated. Pulse/chase analysis revealed a similar result to that 
seen with full-length HO-1: in the presence of the SPP D/A mu-
tant, a single slower migrating band representing the uncleaved 
form of HO-1 short (Fig. 4 B, third and fourth lanes) was de-
tected. This band remained stable over the time course of the 
chase. In the presence of WT SPP, an HO-1 precursor product 
relationship was again seen. At the start of the chase (Fig. 4 B, 
first lane) both cleaved and uncleaved forms of HO-1 were detected, 
and by the 1-h chase point, both fragments had lost intensity, with 
only the faster migrating, cleaved form of HO-1 remaining visible 
(Fig. 4 B, second lane). We conclude that HO-1 is a substrate 
of SPP and HO-1 cleavage is required for its degradation.
To determine whether SPP cleavage of substrate (HO-1) 
precedes its extraction from the ER membrane, and subsequent 
proteasome-dependent degradation, we separated cells from a 
pulse–chase experiment into membrane pellets and soluble frac-
tions, in the presence or absence of lactacystin (Fig. 4 C). In the 
presence of WT SPP, cleavage and release of HO-1 into the sol-
uble fraction was proteasome independent, but the cleaved form 
of HO-1 was degraded in a proteasome-dependent pathway. In 
contrast, the SPP D/A mutant stabilized the uncleaved higher 
molecular mass HO-1 polypeptide, which accumulated in the 
membrane fraction and was not released into the soluble cyto-
solic fraction. Collectively, these experiments demonstrate an 
absolute requirement for SPP catalytic activity for the cleavage 
and subsequent extraction of HO-1 from the lipid bilayer into 
the cytosol for proteasome-dependent degradation.
Figure 2. Endogenous HO-1 is degraded in an SPP-dependent path-
way. (A–C) Immunoblot for HO-1. (A) WT (HCT116+/+) and SPP knockout 
(B4/) cells were treated with 50 µM hemin (+) for 15 h to induce HO-1. 
Hemin was removed, and cells were harvested at the times indicated 
(0/6/12/24 h after hemin induction), using -actin as a loading control. 
Cycloheximide was added to all samples after hemin removal to block de 
novo protein synthesis. (B) WT (HCT116+/+) and SPP knockout (B4/) cells 
were complemented by overexpression of either SPP WT– or SPP D/A– 
expressing vectors. The complemented cells were harvested 24 h after hemin 
induction and blotted for HO-1. (C) SPP RNAi– or mock-transfected HeLa 
cells were treated with 50 µM hemin for 20 h to induce HO-1. Hemin was 
removed, and cells were harvested at the times indicated after hemin induc-
tion (hours postchase) and blotted for HO-1. Cycloheximide was added to 
all samples after hemin removal to block de novo protein synthesis. Inset 
shows depletion of SPP at t = 0 h. The chart at the bottom represents the quan-
tification of three independent mock and SPP RNAi transfections. Scanned 
images were quantified using ImageJ v.1.46r (National Institutes of Health; 
Schneider et al., 2012). HO-1 levels are normalized against -actin levels. 
The error bars represent the standard error.
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region for cleavage by SPP was confirmed with two chimeric 
GFP proteins, with N-terminal GFP fused to either the TMD of 
SPP-sensitive HO-1 (GFP:HO-1TMD) or SPP-insensitive Ube2J1 
(GFP:Ube2J1TMD). The HO-1 TMD construct was degraded 
in the presence of WT SPP and stabilized by mutant D/A SPP, 
(Z-LL)2, and bortezomib (Fig. 5, D and E), whereas GFP: 
Ube2J1TMD remained SPP insensitive (Fig. 5 D). Collec-
tively, these results suggest that cleavage by SPP, subsequent 
dislocation, and proteasome-mediated degradation are depen-
dent on the transmembrane region.
SPP-mediated cleavage and dislocation are 
dependent on a minimal luminal domain
HO-1 has 266 predicted cytosolic N-terminal residues but only 
a very short luminal C-terminal tail (three to five residues). To 
determine how extension of the N-terminal cytosolic domain or 
C-terminal luminal domain affected HO-1 stability, we initially 
added a nine-residue HA tag to either the N or C terminus of 
HO-1 (HA–HO-1 and HO-1–HA, respectively). This short tag 
did not affect the rapid degradation or stabilization of HO-1 in 
cells expressing exogenous WT or D/A mutant SPP, respectively 
proteins, we tested the stability of four additional tail-anchored 
proteins: cytochrome B5A, the stress-inducible RAMP4 and 
RAMP4-2 (Yamaguchi et al., 1999), and Ube2J1. Like HO-1, 
cytochrome B5A RAMP4 and RAMP4-2 were rapidly degraded 
in the presence of WT SPP, in an SPP-dependent pathway, and 
were stabilized by D/A SPP (Fig. 5 A), whereas Ube2J1 was 
insensitive to SPP. To determine whether SPP affected degrada-
tion of endogenous protein, we induced RAMP4 with tunica-
mycin and, after removal of this stimulus, monitored the 
degradation of HO-1 in the presence or absence of SPP. As seen 
with endogenous HO-1, the degradation of RAMP4 was mark-
edly reduced after siRNA-mediated SPP depletion in HeLa cells 
(Fig. 5 B). These data suggest that SPP-mediated cleavage and 
subsequent degradation are a feature of the degradation of many, 
but not all, ER-resident tail-anchored proteins.
Our results were extended with a series of chimeric pro-
teins composed of the cytosolic and TMDs of HO-1, cytochrome 
B5A, or Ube2J1. All constructs containing the TMD of HO-1 
and cytochrome B5A were degraded in an SPP-dependent path-
way, whereas the TMD of Ube2J1 prevented SPP-dependent 
degradation (Fig. 5 C). The importance of the transmembrane 
Figure 3. Catalytically active SPP is required 
for HO-1 degradation. (A) Immunoblot for 
HO-1. Endogenous HO-1 was induced with 
hemin (as in Fig. 2 C) in HEK-293T cells, and 
cells were harvested at indicated times, after 
incubation with control (DMSO), proteasome 
inhibitor (lactacystin), or SPP inhibitor ((Z-LL)2 
ketone). (B) HA immunoblot of overexpressed 
HA–HO-1 and HA-Sec11C cotransfected with 
GFP (mock), WT, or dominant-negative (D/A) 
SPP. (C) HA and myc immunoblots showing 
interaction between SPP (D/A) and HO-1. 
HEK-293T cells were cotransfected with empty 
myc vector or D265A SPP-myc KKEK (D/A 
SPP-myc) and either HA–HO-1 or HA-Ube2J1. 
NP-40/DOC lysates and eluates from the HA 
and myc immunoprecipitations were probed 
for the indicated proteins. Approximately 3% 
of the total cell lysates and 25% of the immuno-
precipitate eluates were loaded on the gels. 
Separate blots were exposed independently.
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was inserted in the correct type II orientation, we confirmed that 
an N-linked glycosylation motif engineered into the GFP domain 
was both glycosylated and Endoglycosidase H sensitive (Fig. 6 B, 
first through fourth lanes), confirming its type II orientation in 
the ER membrane.
To further investigate the requirements for SPP-mediated 
cleavage, in particular how a bulky ER-luminal domain affects 
susceptibility to SPP-mediated cleavage and subsequent dislo-
cation, we designed additional constructs, HA–HO-1.SP N/QIT 
and HA–HO-1.SP N/QIT (von Heijne, 1986; Honsho et al., 
1998). These HO-1 constructs have a luminal extension consist-
ing of a T7 tag with an N-linked glycosylation motif (NIT) or 
control motif (QIT) and are otherwise identical except for five 
additional residues inserted between the membrane and the 
T7 tag of both constructs, which make HA–HO-1.SP N/QIT 
susceptible to cleavage by SP (Fig. 6 C, schematic), whereas the 
residues in HA–HO-1.SP N/QIT are SP insensitive. Upon in-
sertion into the ER membrane, both NIT-containing proteins 
were glycosylated, as determined by Endoglycosidase H sensi-
tivity (Fig. 6 C, top). HA–HO-1.SP NIT was relatively insen-
sitive to SP and remained stable in the presence of WT SPP 
(Fig. 6 A). We used this construct to confirm that the SPP- 
mediated cleavage of HO-1 occurs within the TMD, by comparing 
the expression of HA–HO-1 and HO-1–HA when coexpressed 
with WT SPP in the presence or absence of proteasome in-
hibitor. The HA–HO-1 protein is detected by both anti-HA 
and anti–HO-1 antibodies, when coexpressed with WT SPP, and 
detection is enhanced with bortezomib (Fig. S4, top). Upon trans-
fer of the HA epitope from the N to the C terminus (HO-1–HA), 
both the noncleaved and cleaved form remain detectable with 
the HO-1 antibody, with the cleaved form protected by bortezo-
mib. In contrast, HA now only detects the noncleaved form, and 
there is no rescue with bortezomib, as the small cleaved frag-
ment is likely to be rapidly degraded (Fig. S4, bottom). There-
fore, these experiments suggest that SPP-mediated cleavage of 
HO-1 occurs within the TMD.
Further luminal extension with the much larger GFP (238 
residues; HO-1:GFP) prevented WT SPP-mediated degradation 
(Fig. 6 B, first through fourth lanes), whereas GFP fused to the 
cytosolic terminus (GFP:HO-1) was still rapidly degraded in 
the presence of WT SPP and stabilized by the SPP D/A mutant 
(Fig. 6 B, fifth through eighth lanes). To ensure that HO-1:GFP 
Figure 4. HO-1 cleavage by catalytically active SPP is required for its dislocation from the ER membrane and subsequent proteasome-mediated degrada-
tion. (A and B) Cleavage of HO-1 was visualized by metabolic label and pulse/chase analysis. Full-length HA–HO-1 (A) or truncated HO-1 (HA–HO-1short; B) 
plasmids, together with either WT SPP or mutant (D/A) SPP plasmids were cotransfected into HEK-293T cells and [35S]methionine/cysteine pulse labeled 
for 15 min. HO-1 was recovered by HA immunoprecipitation (IP) at the chase times indicated and analyzed by SDS-PAGE and autoradiography. The 
black line indicates that the middle lanes from gel were removed, so the second and third lanes were not contiguous. (C) HA–HO-1short was transfected into 
HEK-293T cells together with either WT or mutant D/A SPP and radiolabeled as in B in the presence or absence of the proteasome inhibitor lactacystin. 
Postnuclear lysates were separated into membrane fractions (pellet) and soluble fractions (supernatant [Sup]) before HA immunoprecipitation, SDS-PAGE, 
and autoradiography.
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Figure 5. ER-resident tail-anchored proteins are cleaved and degraded in an SPP-dependent pathway. (A) HA immunoblot in HEK-293T cells cotransfected 
with either HA–HO-1, HA-CYB5A, HA-RAMP4, HA–RAMP4-2, or HA-Ube2J1 and either GFP (mock), WT, or dominant-negative (D/A) SPP as indicated. 
The SPP inhibitor (Z-LL)2 ketone and the proteasome inhibitor lactacystin (PI) were added to the indicated samples 16 h before harvest. (B) Immunoblot for 
RAMP4. Mock- or SPP RNAi–transfected HeLa cells were treated with 1 µM tunicamycin for 17 h to induce RAMP4. Cells were harvested at 0 and 24 h 
after tunicamycin. Unstimulated cells (un.) were harvested at t = 0 h. The inset shows depletion of SPP at t = 0 h. (C) HA immunoblot in HEK-293T cells. 
Cotransfection with either WT or dominant-negative (D/A) SPP or GFP () and full-length or chimeric proteins as indicated. Chimeras contain the cytosolic 
domain of one protein fused to the transmembrane and luminal domain (TMD) as indicated by the color coding. Black lines indicate that intervening lanes 
have been spliced out. (D) Immunoblot for GFP in HEK-293T cells transfected with GFP fused to either the TMD of HO-1 (GFP:HO-1TMD) or the TMD of 
Ube2J1 (GFP:Ube2J1TMD) and either the empty vector (mock), WT, or dominant-negative (D/A) SPP as marked. (E) Immunoblot for GFP in HEK-293T 
cells transfected with GFP fused to the TMD of HO-1 (GFP:HO-1TMD) and either WT or dominant-negative (D/A) SPP. Samples were treated with the SPP 
inhibitor (Z-LL)2 ketone or the proteasome inhibitor Bortezomib.
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Figure 6. The length of the luminal domain is a critical determinant of SPP-mediated cleavage. (A) Immunoblot for HO-1 in HEK-293T cells cotransfected 
with either N-terminal (HA–HO-1) or C-terminal (HO-1–HA) HO-1 with or without WT, dominant-negative (D/A) SPP, or GFP (mock [M]) as indicated. 
(B) Immunoblot for GFP in HEK-293T cells transfected with either N-terminal (GFP:HO-1) or C-terminal (HO-1:GFP) GFP-tagged HO-1 with or without WT 
or dominant-negative (D/A) SPP. The GFP tag used in these constructs contained a double mutation (D82N and F84T; Grotzke et al., 2013) to generate 
an N-glycosylation site. Samples were subjected to Endoglycosidase H treatment (±Endo H). (C) Immunoblot for HA in HEK-293T cells transfected with 
HA–HO-1 constructs, which have an additional luminal tag, which starts with (SP) or without (SP) a membrane proximal signal peptidase (SP) cleavage 
site, followed by a T7 tag and finishing with either a functional C-terminal N-glycosylation site (NIT) or a false N-glycosylation site (QIT) as shown in the 
schematic. These constructs were cotransfected with GFP (mock; top), WT, or (D/A) SPP and subjected to Endoglycosidase H treatment as indicated.
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from the ER membrane. Indeed, TRC8 was recently reported 
to be the E3 ligase responsible for the ubiquitination and deg-
radation of HO-1 (Lin et al., 2013). This suggests that both 
ubiquitination and intramembrane cleavage are required for 
HO-1 dislocation. We find overexpressed TRC8 readily de-
creases induced endogenous HO-1 (Fig. 7 A), but in the cell 
lines tested, neither RNAi nor shRNA-mediated TRC8 deple-
tion reproducibly protected HO-1 from degradation, suggest-
ing the involvement of more than one E3 ligase or a redundancy 
in E3 ligase usage. With these caveats, we further examined 
the role of ubiquitination in HO-1 extraction, in particular to 
ascertain whether SPP cleavage enables HO-1 ubiquitination 
by overexpressed TRC8 or vice versa. Overexpressed HA–
HO-1 was immunoprecipitated from bortezomib-treated cells 
that co-overexpress either control (GFP), TRC8, or the TRC8 
RING mutant (Stagg et al., 2009) with SPP WT or SPP D/A. 
Ubiquitinated HO-1 was readily detected after bortezomib 
treatment in TRC8/SPP but not TRC8 RING/SPP– or GFP/
SPP-treated cells. The ubiquitinated HO-1 species were more 
(Fig. 6 C, middle, first through fourth lanes). In contrast, HA–
HO-1.SP NIT was cleaved by SP and was rapidly degraded in the 
presence of WT SPP. When expressed with the SPP D/A mutant, 
HA–HO-1.SP NIT was stabilized in its SP cleaved, faster migrat-
ing form (Fig. 6 C, middle, fifth through eighth lanes). Both the 
nonglycosylated HA–HO-1.SP QIT and HA–HO-1.SP QIT 
were degraded in the presence of WT SPP (Fig. 6 C, bottom, first, 
second, fifth, and sixth lanes) but stabilized by the SPP D/A mu-
tant (Fig. 6 C, bottom, third, fourth, seventh, and eighth lanes).
These results show that cleavage by SPP and subsequent 
dislocation of HO-1 can be inhibited by either a bulky luminal 
extension (e.g., GFP) or an N-linked glycan. If the polypeptide is 
liberated, in the latter case by the cleavage of the ectodomain by SP, 
SPP-mediated cleavage proceeds, and the protein is degraded.
SPP cleavage triggers HO-1 ubiquitination 
by overexpressed TRC8
The association of TRC8 with SPP (Stagg et al., 2009) suggested 
a role for this E3 ligase in HO-1 ubiquitination and extraction 
Figure 7. TRC8 ubiquitinates cleaved HO-1. 
(A) TRC8 expression decreases endogenous 
HO-1 levels. Immunoblot for HO-1. HEK-293T 
cells transfected with either GFP (mock), TRC8 
FLAG, or TRC8 RING FLAG were induced 
for 20 h with 50 µM hemin. Cells were har-
vested at the indicated times after hemin re-
moval. (B) TRC8 ubiquitinates SPP-cleaved 
HO-1. HA, FLAG, myc, and ubiquitin immuno-
blots after cotransfection of HA–HO-1 with 
GFP (mock), TRC8 FLAG, TRC8 RING FLAG, 
and either SPP myc KEKK (WT) or SPP myc 
KEKK D265A (D/A), in the presence (+) or 
absence () of Bortezomib. Lysates and HA 
(HA–HO-1) immunoprecipitations (performed 
under denaturing conditions) were probed for 
the indicated proteins.
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prominent with SPP WT as compared with SPP D/A, despite 
much less HA–HO-1 being detected with SPP WT (Fig. 7 B). 
These experiments suggest that cleavage of HA–HO-1 is the 
primary event that precedes and may stimulate ubiquitination 
by TRC8, such that if cleavage does not occur, less HA–HO-1 
ubiquitination is detected.
SPP is not required for the US2-mediated 
degradation of MHC-I molecules
SPP was previously implicated in the US2-mediated degradation 
of MHC-I (Loureiro et al., 2006), though no requirement for 
SPP’s catalytic activity was reported. Despite successful RNAi- 
and shRNA-mediated depletions of SPP, we were unable to 
demonstrate a role for this protease in the US2-mediated deg-
radation of MHC-I (Fig. S5). Because RNAi-mediated SPP 
depletion may not effectively abolish all enzymatic activity, 
we examined US2 function in the SPP/ cells. Expression of 
US2 in the SPP knockout cells caused a decrease in cell sur-
face MHC-I expression (Fig. 8 A), and pulse–chase analysis of 
[35S]methionine/cysteine-radiolabeled cells showed rapid deg-
radation of MHC-I with kinetics identical to SPP-replete WT 
parental cells (Fig. 8 B). Our results suggest that despite bind-
ing TRC8, SPP is not required for the US2-mediated degrada-
tion of MHC-I in these cells.
Discussion
Tail-anchored proteins represent 3–5% of all membrane proteins 
(Kalbfleisch et al., 2007). Here, we identify a novel function for 
SPP in the intramembrane cleavage and turnover of endogenous 
HO-1, an ER-resident tail-anchored protein. Our results suggest 
that SPP-mediated proteolysis is not limited to HO-1 but rep-
resents a more generalized pathway for turnover of additional 
members of this protein family.
The association of SPP with the TRC8 E3 ligase suggested 
a role for this intramembrane cleaving protease in ER protein 
turnover (Stagg et al., 2009), but we were unable to confirm a role 
for SPP in the US2-mediated degradation of MHC-I (Loureiro 
et al., 2006). However, the SPP somatic cell knockout enabled a 
functional proteomics screen, which identified HO-1 as a novel 
substrate of SPP, and emphasizes the utility of this unbiased 
approach. The predicted accumulation of membrane-embedded 
signal sequences from the ER membrane of SPP-deficient cells 
was not seen, probably a result of the difficulty of detecting short 
hydrophobic peptides by mass spectrometry. The twofold in-
crease in the abundance of HO-1 in SPP knockout cells, though 
modest, likely reflects the very low resting level of constitutive 
HO-1 in nonstimulated cells. The ability to induce HO-1 ex-
pression, remove the stimulus, and monitor HO-1 degradation 
Figure 8. SPP knockout HCT116 cells are competent for US2-mediated MHC class I dislocation. (A) Cytofluorometric analysis of surface MHC class I 
expression (W6/32) in HCT116 clones transduced with mock lentivirus, US2-expressing lentivirus, or US11-expressing lentivirus. Solid black traces are 
cells stained with secondary antibody only (anti–mouse Alexa Fluor 647). (B) WT (SPP+/+) and SPP knockout (SPP/) HCT116 cells ± HA-US2 were pulse 
radiolabeled for 10 min, and MHC class I (W6/32) and US2 (rabbit anti-US2) were immunoprecipitated from detergent lysates at the times indicated. 
IP, immunoprecipitation.
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substrate. In the case of a single-pass type II transmembrane 
protein, this would simply involve removal of the luminal ectodo-
main. For a more complex polytopic protein, multiple proteolytic 
cleavage events might be required to expose a type II–orientated 
TMD to SPP-mediated cleavage. A role for SPP in ER quality 
control was originally suggested after the identification of SPP 
as a cross-linking partner of misfolded opsin (Crawshaw et al., 
2004), and other membrane proteins associate with inactive SPP 
(Schrul et al., 2010).
HO-1 is rate limiting for the oxidative degradation of heme 
and is rapidly induced in conditions of oxidative stress, consis-
tent with its critical in vitro and in vivo role as a cytoprotective 
enzyme (Poss and Tonegawa, 1997), through the antioxidative 
properties of biliverdin and carbon monoxide (Abraham and 
Kappas, 2008). Regulation of HO-1 expression is tightly con-
trolled and occurs at the transcriptional (Yang and Zou, 2001), 
posttranscriptional (Leautaud and Demple, 2007), and posttrans-
lational level (Lin et al., 2008). Our estimated half-life of HO-1 
of 10 h is similar to that shown after treatment with cobalt proto-
porphyrin (Lin et al., 2008). Nitric oxide may be even more ef-
fective at increasing HO-1 concentration, through stabilization 
of HO-1 mRNA (Leautaud and Demple, 2007), consistent with 
the cytoprotective role of HO-1 in response to different forms of 
cellular stress. Although we do not see a stress-induced increase 
in SPP, as observed for other ERAD components, removal of 
the inducing signal leads to HO-1 degradation. Indeed, prote-
olysis provides an effective first step of enzyme inactivation, as 
soluble HO-1 has much reduced activity (Lin et al., 2007).
Therefore, in the simplest model for SPP-mediated HO-1 
proteolysis, the rate of turnover of HO-1 by SPP does not change, 
but after the stimulation of HO-1 synthesis, its rate of produc-
tion exceeds degradation, allowing HO-1 to accumulate in the 
ER membrane. After removal of this stimulus, the HO-1 is turned 
over by SPP until it returns to its resting equilibrium. In this re-
gard, the half-life of other reported endogenous mammalian 
ERAD substrates is shorter than HO-1, varying from 30 to 90 min 
(Burr et al., 2011; Chen et al., 2011; Tyler et al., 2012), suggest-
ing that SPP is involved in the turnover of this ER-resident pro-
tein and maintenance of ER homeostasis rather than regulation 
of misfolded proteins.
The degradation signal for SPP cleavage of HO-1 is likely 
imparted in the transmembrane region as transfer of this domain 
rendered an unrelated protein sensitive to SPP-mediated degra-
dation. The length of the luminal extension is clearly critical, 
and UBE2J1, which is not an SPP substrate, has a longer lumi-
nal portion than the other tail-anchored proteins. However, en-
gineered constructs with similar length luminal extensions were 
still cleaved by SPP. Although the TMD of HO-1 appears re-
sponsible for turnover, and is cleaved by SPP, it is unlikely to be 
disordered, as the transmembrane spans are in an -helical con-
formation (Hwang et al., 2009). HO-1 oligomerization through 
its TMD is important for its catalytic activity. Degradation of 
HO-1 could therefore be triggered by loss of the oligomeric 
state, allowing access of SPP to the HO-1 monomer. However, 
a W270N HO-1 mutant, reported to interfere with oligomer-
ization (Hwang et al., 2009), appeared less susceptible to SPP- 
mediated proteolysis (unpublished data). The formation of stable 
over time provides a useful system to study the physiological 
turnover of an endogenous ER-resident protein.
Tail-anchored proteins represent an extreme example of 
type II transmembrane proteins with very short C termini in the 
ER lumen. The orientation of the catalytic sites in SPP’s TMDs ac-
counts for SPP’s specificity for type II–oriented proteins (Weihofen 
et al., 2002). We did not identify type II proteins as SPP sub-
strates, probably because the size of the luminal domain is criti-
cal in determining cleavage and subsequent degradation of HO-1 
by SPP. Although Sec11c, a component of the SP complex, was 
our top hit by mass spectrometry from HCT116 cells, this could 
not be confirmed in HEK-293T cells, and we don’t find Sec11c 
to be an SPP substrate.
The location of the hydrophobic transmembrane region 
very near the C terminus of HO-1 is characteristic for all tail-
anchored proteins. Their insertion into the ER membrane is post-
translational and differs from cotranslational insertion in requiring 
TMD-selective cytosolic chaperones including the distinct GET 
(guided entry of tail-anchored proteins) pathway. (Shao and 
Hegde, 2011). Dislocation of tail-anchored proteins from the ER 
membrane may also be distinct from more conventional ERAD 
substrates. The absence of any substantive luminal domain in 
HO-1 means there is no clear requirement for luminal adaptors 
such as SEL1L to recognize luminal components. Nor is there 
necessarily a need to invoke a channel for the dislocation of tail-
anchored proteins. Indeed, in the absence of any luminal domain, 
the main barrier to overcome is the energy required to dislocate 
the hydrophobic transmembrane region. In this regard, intramem-
brane cleavage of the TMD by SPP may be sufficient to destabi-
lize the protein, reduce the energy barrier, and promote membrane 
extraction. Cleaved hydrophobic segments may also be less prone 
to aggregation once they are exposed to the cytosol.
Enzymatic cleavage by SPP and the related SPP-like pro-
teases is classically viewed as a series of sequential proteolytic 
processing events (Voss et al., 2013). SPP’s cleavage of tail- 
anchored proteins provides a unique example in which SPP’s 
activity toward its substrate is the primary proteolytic event and 
does not require the sequential two-step proteolytic process, as 
seen after the cotranslational insertion of type I membrane pro-
tein with a signal sequence. Because tail-anchored proteins have 
no luminal domain, they require no initial processing, and cleav-
age by SPP is therefore the primary proteolytic event. SPP’s ac-
tivity may therefore have evolved for cleavage of tail-anchored 
proteins and was subsequently used for cleavage of other type II– 
orientated proteins after ectodomain removal.
Insertion of a small nine-residue luminal extension did not 
affect HO-1 stability, but the introduction of GFP or an N-linked 
glycan inhibited SPP cleavage and prevented degradation. This 
could be overcome by insertion of a SP recognition motif after 
the transmembrane region, with primary cleavage by SP liberat-
ing the HO-1 polypeptide for subsequent cleavage by SPP and 
degradation, presumably by allowing SPP access to the cleav-
age site. This is in keeping with the known activity of SPP after 
ectodomain shedding (Lemberg and Martoglio, 2002). SPP-
mediated proteolysis may therefore enable dislocation of any 
protein with a type II orientation but, in such a case, would re-
quire an initiating proteolytic event to allow SPP to access its 
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Construction and isolation of HM13 (SPP) gene knockout
To construct the HM13 gene knockout, 5 and 3 arms of homology, flanking 
the HM13 exon 3, were generated by long-range PCR (LATaq; Takara Bio Inc.) 
from human genomic DNA, following the manufacturer’s recommended condi-
tions. To create the gene-targeting construct, the 5 arm (5 kb) was introduced 
into the multicloning Spe1–Stu1 site of plasmid pOT7. Next, the 3 arm 
(4.3 kb) was ligated (EcoR1–Not1) to generate pOT7:5:3. For the conditional 
targeting construct, HM13 exon 3 + LoxP was ligated directly upstream of the 
3 arm with Bgl2–EcoR1 to generate pOT7:5:E3M:3. Using two consecu-
tive Gateway Cloning Technology reactions (Life Technologies), the promoter-
less mammalian positive selection cassette from plasmid pL1L2GT0-NEO 
(Skarnes et al., 2011) was inserted between the homology arms. This created 
the following plasmids: pOT7:5:3:SPPneo for permanent locus disruption and 
pOT7:5:E3M:3:conSPPneo for conditional gene targeting. For the first allele 
targeting, 30 µg plasmid pOT7:5:E3M:3:conSPPneo, linearized with Sal1, 
was electroporated into 1 × 107 HCT116 cells (0.55 kV, 25 µF, and 200 Ω; 
Gene Pulser; Bio-Rad Laboratories). After 48 h of incubation without selection, 
cells were split 1:10 into medium containing 1.8 mg/ml G418 (Life Technolo-
gies). After 2 wk of selection, genomic DNA was isolated from individual 
clones (Puregene Core Kit B; QIAGEN) and analyzed by long-range PCR to 
identify correct gene-targeting events. For further confirmation, HM13 mRNA, 
isolated from positive clones, was reverse transcribed into cDNA, ampli-
fied by PCR, and sequenced to confirm correct integration. To remove the tar-
geting cassette and obtain the conditionally targeted allele, 2 × 106 clone 
27 cells were electroporated (program D-32) with 2 µg pGFP_FLIP_IRES_PURO 
plasmid using Amaxa Kit V (Lonza). 2 d later, cells were selected with 1 µg/ml 
puromycin for 48 h (EMD Millipore) and seeded into 96-well plates at a cell 
density of 0.3 cells/well. Clones were replicate plated into either G418 or 
puromycin, and sensitive clones were confirmed for cassette loss by long-
range PCR. This generated clone 27FLIP. The second allele of HM13 was tar-
geted in clone 27FLIP for permanent disruption using linearized plasmid 
pOT7:5:3:SPPneo and the conditions described for the first allele targeting 
using plasmid pOT7:5:E3M:3:conSPPneo. Long-range PCR was used to iden-
tify G418-resistant clones that had lost exon 3 at the second allele.
To obtain fully SPP-deficient (/) cells, the LoxP-flanked exon 3 of 
HM13 was removed after lentiviral transduction with pHRSinGFP:Cre. GFP-
positive clones were screened for Cre-mediated loss of HM13 exon 3 by 
long-range PCR. This resulted in clones B4 and B6-1.
Immunoblotting
Cells were either lysed directly using Laemmli loading buffer + Benzonase nu-
clease (Sigma-Aldrich) or using either 1% Triton X-100 or NP-40/DOC (1% 
NP-40 and 0.5% sodium deoxycholate) in TBS (10 mM Tris, pH 7.4, 150 mM 
NaCl, 1 mM CaCl2, 1 mM MgCl2, and 10 µM ZnCl2) with protease inhibitors 
(1 mM iodoacetamide [Sigma-Aldrich], protease inhibitor cocktail [Roche], 
and 0.5 mM PMSF [Sigma-Aldrich]). Postnuclear lysates were then diluted into 
Laemmli buffer before SDS-PAGE (tris-tricine for core or tris-glycine for all other 
proteins). Samples were transferred to either nitrocellulose or polyvinylidene 
difluoride membranes, blocked, and incubated with primary and secondary 
antibodies as noted. Proteins were then visualized with chemiluminescent sub-
strates (Thermo Fisher Scientific) or infrared imaging (Odyssey; LI-COR Bio-
sciences). All blots were visualized by chemiluminescence unless otherwise 
indicated in the figure legend. For coimmunoprecipitation experiments, cells 
were lysed in NP-40/DOC in TBS plus protease inhibitors. Postnuclear lysates 
were precleared on IgG-Sepharose beads (GE Healthcare) and subjected 
to immunoprecipitation with EZview red anti-HA or anti–c-myc affinity gels 
(Sigma-Aldrich) as noted. Samples were washed with NP-40/DOC in TBS, 
dissociated from the beads by heating to 70°C for 5 min in reducing SDS 
sample buffer, and separated by SDS-PAGE and processed as described ear-
lier for cell lysates. The HA–HO-1 ubiquitin immunoprecipitation experiment 
was performed as described for the coimmunoprecipitation experiments, ex-
cept it was performed as a double HA immunoprecipitation, with elution from 
the first immunoprecipitation in 1% SDS in TBS and heating to 65°C for 5 min. 
The eluate was diluted to 0.1% SDS using NP-40/DOC in TBS buffer before 
the second immunoprecipitation and processed as described for the standard 
coimmunoprecipitation experiments.
Flow cytometry
Cells were stained with W6/32 monoclonal antibody (conformational 
MHC class I), followed by goat anti–mouse Alexa Fluor 647 (Invitrogen). 
Samples were processed on a FACSCalibur (BD) machine, and data were 
analyzed using FlowJo software (Tree Star).
Metabolic label and radioimmune precipitation
Radioimmune precipitation was performed as previously described (Burr 
et al., 2011). Cells were starved for 30 min in Met- and Cys-free medium and 
transmembrane complexes might serve to sequester potential 
tail-anchored substrates away from SPP, with UBE2J1, for ex-
ample, forming transmembrane associations with other ERAD 
components. This requires further examination, but our overex-
pression experiments should have overcome this possible effect. 
Helix-destabilizing residues in the membrane-spanning residues 
of signal peptides are reported to be important for intramem-
brane cleavage by SPP (Lemberg and Martoglio, 2002), and a 
larger range of tail-anchored proteins will need to be examined 
to determine whether this is also the case for these substrates.
The recent study of TRC8 as the E3 ligase responsible for 
the ubiquitination and degradation of HO-1 (Lin et al., 2013) 
fits well with our model of TRC8 binding SPP and suggests that 
both ubiquitination and intramembrane cleavage are required 
for HO-1 dislocation. Despite TRC8 overexpression readily de-
creasing HO-1 protein levels, neither RNAi- nor shRNA-mediated 
TRC8 depletion reproducibly protected HO-1 from degradation, 
suggesting that more than one E3 ligase may be involved or a 
redundancy in E3 ligase usage. Our TRC8 overexpression ex-
periments indicate that SPP-mediated cleavage of HA–HO-1 
precedes and may therefore trigger subsequent HO-1 ubiquitina-
tion by TRC8. Under these circumstances, cleavage by SPP will 
destabilize the protein and liberate a hydrophobic C-terminal 
peptide from the HO-1 TMD, which may in turn act as the de-
gron for TRC8-mediated ubiquitination.
In summary, we have identified tail-anchored proteins as 
novel substrates of SPP and identified a crucial role for this 
enzyme in the intramembrane cleavage and subsequent degra-
dation of HO-1 and other ER-resident tail-anchored proteins. 
A potential signaling role for HO-1 has been suggested, as a 
C-terminal truncated proteolytic fragment of HO-1 migrates to 
the nucleus to initiate a transcriptional program. Cleaved signal 
sequences such as the preprolactin signal peptide are also bioac-
tive after their release from the ER membrane. Whether all the 
SPP-cleaved HO-1 is degraded by the proteasome or whether 
this pathway may act to initiate a transcriptional program for 
up-regulation of cytoprotective genes merits further study.
Materials and methods
Cell culture
HeLa cells were cultured in RPMI 1640 (PAA Laboratories). All other cells were 
cultured in Iscove’s Modified Dulbecco’s Media (PAA Laboratories) with 10% 
FBS (PAA Laboratories) and 100 U/ml penicillin and 100 µg/ml streptomycin 
(pen/strep; Sigma-Aldrich), in a humidified incubator with 5% CO2 at 37°C. 
HO-1 was induced with 50 µM hemin (Sigma-Aldrich) in culture medium 
for 16–24 h, and degradation was induced by washing out the hemin once 
with PBS followed by incubation for 16–24 h in culture medium.
Antibodies
The following antibodies were used: rabbit anti-HA (PRB-101P; Covance), 
rabbit anti-SPP (ab16080; Abcam), rabbit anti–hepatitis C core (R4210; gift 
from J. McLauchlan, Medical Research Council–University of Glasgow Cen-
tre for Virus Research, Glasgow, Scotland, UK), mouse anti–HO-1 (ab13248; 
Abcam), mouse anti-myc (9B11; Cell Signaling Technology), mouse anti–-
actin (A5316; Sigma-Aldrich), rabbit anti-RAMP4/4-2 (A18; sc-85114; 
Santa Cruz Biotechnology, Inc.), mouse anti-calnexin (AF8) and rabbit anti-
GFP (A11122; Invitrogen), rabbit anti-US2 (177–5; ER luminal domain; a 
gift from E. Wiertz, University Medical Center Utrecht, Utrecht, Netherlands), 
mouse anti–MHC-I (W6/32; ATCC), goat anti–mouse Alexa 647 (Invitro-
gen), goat anti–mouse IRDye 800 and goat anti–rabbit IRDye 680 (LI-COR 
Biosciences), and goat anti–mouse HRP and goat anti–rabbit HRP (Jackson 
ImmunoResearch Laboratories, Inc.).
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Flag3-full-length HO-1 (a gift of L.-Y. Chau, Institute of Biomedical Sciences, 
Academia Sinica, Taipei, Taiwan), into pHRSIN HA (N terminus) pgkPURO 
and pHRSIN HA (C terminus) pgkPURO lentiviral expression plasmids 
(HO-1–HA C-terminal tag sequence is AAAYPYDVPDYA*; The asterisk represents 
termination via a STOP codon.). pHRSIN HA–HO-1short puro (HA–HO-1short) 
contains a 154–amino acid deletion (30–184) engineered by site-directed 
deletion of nucleotides 91–552 of the HO-1 coding sequence cloned into 
pHRSIN HA (N terminus) pgkPURO. pHRSIN HA-Sec11c puro (HA-Sec11c) 
was generated by PCR amplification from pCMV6-XL5 Secllc (OriGene) and 
cloned into pHRSIN HA (N terminus) pgkPURO. pHRSIN HA-Ube2J1 puro 
(HA-Ube2J1) was generated by PCR amplification from IMAGE clone 
4137664 and cloned into pHRSIN HA (N terminus) pgkPURO. pHRSIN HA 
CYB5A puro (HA-CYB5A), pHRSIN HA RAMP4 puro (HA-RAMP4), and 
pHRSIN HA RAMP4-2 puro (HA–RAMP4-2) were generated by PCR amplifi-
cation from a human fetal brain yeast two-hybrid cDNA library (Invitrogen) 
and cloned into pHRSIN HA (N terminus) pgkPURO. pHRSIN EmGFPglyc:
HO-1 (GFP:HO-1) and pHRSIN HO-1.EmGFPglyc (HO-1:GFP) were gen-
erated by subcloning WT HO-1 into pHRSIN EmGFPglyc (N terminus) and 
pHRSIN EmGFPglyc (C terminus) lentiviral expression plasmids. EmGFPglyc is 
modified to include a glycosylation site by the introduction of D82N and 
F84T changes, as previously described (Grotzke et al., 2013). pHRSIN HA–
HO-1:SP:T7:Glyc puro (HA–HO-1.SP NIT), pHRSIN HA–HO-1:SP:T7:Glyc 
puro (HA–HO-1.SP NIT), pHRSIN HA–HO-1:SP:T7:Glyc puro (HA–HO-
1.SP QIT), and pHRSIN HA–HO-1:SP:T7:Glyc puro (HA–HO-1.SP QIT) 
were generated by cloning the full-length heme oxygenase coding sequence 
(minus the stop codon) along with an oligonucleotide pair encoding either a 
short SP cleavage or SP cleavage-modifying sequence, a T7 tag (MASMT-
GGQQMG), and a glycosylation (NIT) or false glycosylation (QIT) sequence 
into pHRSIN HA (N terminus) pgkPURO. The short SP cleavage-modifying 
sequence in HA–HO-1.SP constructs demonstrated enhanced cleavage by 
SP compared with the sequence encoded in HA–HO-1.SP constructs. The 
translated C-terminal tag sequences are HA–HO-1.SP NIT translation, 
PLPQPMASMTGGQQMGNITQPSPA*; HA–HO-1.SP NIT translation, ALA-
QPMASMTGGQQMGNITQPSPA*; HA–HO-1.SP QIT translation, PLPQ-
PMASMTGGQQMGQITQPSPA*; and HA–HO-1.SP QIT translation, 
ALAQPMASMTGGQQMGQITQPSPA*. pHRSIN GFP:HO-1 TMD (GFP:HO-
1TMD) and pHRSIN GFP:Ube2J1 TMD (GFP:Ube2J1TMD) were generated 
by subcloning the coding sequence for the C-terminal 26 amino acids of 
HO-1 or for the C-terminal 42 amino acids of Ube2J1 into a pHRSIN GFP 
(N terminus) lentiviral expression plasmid. The cytoplasmic domain:transmem-
brane and luminal domain (TMD) fusion proteins examined in Fig. 5 C were 
generated by pairing the cytoplasmic domain from one tail-anchored pro-
tein with the transmembrane and luminal domain of another tail-anchored 
protein, as shown. This was achieved by combining the coding sequence 
(BamHI–SpeI compatible ends) for each cytoplasmic domain (HO-1 amino 
acids 1–261, CYB5A amino acids 1–106, and Ube2J1 amino acids 1–281) 
with the coding sequence (SpeI–NotI compatible ends, including a stop 
codon) for the required transmembrane and luminal domain (TMD) (HO-1 
amino acids 263–288, CYB5A amino acids 108–134, and Ube2J1 amino 
acids 282–318). These were ligated as pairs, into pHRSIN HA (N terminus) 
pgkPURO (BamHI–NotI) to give the required HA-tagged chimeric constructs.
Transient transfection, lentiviral transduction, and RNAi knockdown
HCT116 cells were transfected with jetPRIME (Polyplus Transfection), whereas 
HEK-293T cells were transfected with 293 TransIT (Mirus Bio LLC). Lentiviral 
expression and packaging plasmids were cotransfected into HEK-293T 
cells to produce lentiviral particles encoding HA-US2, HA-US11, Cre re-
combinase, GFP, hepatitis C virus core F130E, SPPwt myc KKEK, or SPP D/A 
myc KKEK. These particles were used to transduce cells, and when appro-
priate, stable clones were isolated after selection with puromycin (EMD 
Millipore). RNAi knockdown of SPP in HeLa cells was performed using an 
ON-TARGETplus siRNA pool against human HM13 (Thermo Fisher Scien-
tific) transfected using Oligofectamine (Invitrogen).
Online supplemental material
Fig. S1 shows a schematic representation of the design and strategy used to 
generate a somatic cell knockout of HM13. Fig. S2 shows PCR confirmation 
of the intermediate and completed HM13 knockout cells. Fig. S3 shows al-
ternate splicing of HM13 mRNA transcripts in the SPP+/+ parental HCT116 
cell line and the SPP/ cell line D19CreB4. Fig. S4 shows that SPP-mediated 
cleavage of HO-1 occurs within its C-terminal TMD, as shown by the ab-
sence of the faster migrating HO-1–HA band when detected with an HA anti-
body compared with detection with an HO-1 antibody. Fig. S5 shows that 
siRNA-mediated knockdown of SPP does not rescue US2-mediated down-
regulation of MHC-I. Table S1 lists the plasmids used in the production of the 
labeled with [35S]methionine/cysteine (NEN; PerkinElmer) for 10 min at 
37°C. The label was chased with complete medium for the times indicated. 
Cells were washed in PBS and lysed in 1% NP-40 in TBS with protease in-
hibitors. Postnuclear lysates were cleared on IgG-Sepharose before immu-
noprecipitation with antibody plus protein A–Sepharose as indicated. After 
washing in 0.1% NP-40 in TBS, samples were dissociated from the beads 
and separated by SDS-PAGE. Radioactive proteins were visualized on a 
Storm scanner (GE Healthcare) and analyzed with ImageQuant TL soft-
ware (GE Healthcare).
Mass spectrometry
WT (+/+) HCT116 and SPP knockout (/) clone B4 were grown in SILAC 
Iscove’s Modified Dulbecco’s Media (Thermo Fisher Scientific) supplemented 
with 10% dialyzed FBS, 500 µg/ml proline (to prevent arginine-proline inter-
conversion), pen/strep, and either light (50 µg/ml Arg0 and Lys0) or heavy 
(50 µg/ml Arg10 and Lys8) amino acids, for nine generations to ensure 
98% incorporation of the labeled amino acids. Cells were washed in PBS, 
harvested by scraping, and resuspended in hypotonic lysis buffer (50 mM 
Tris-HCl, pH 7.4, 1 mM MgCl2, 1 mM CaCl2, 10 µM ZnCl2, and protease 
inhibitors). Cells were lysed by three serial freeze/thaw cycles before nuclei, 
and unlysed cells were removed by a 5,000 g spin. The nonnuclear mem-
branes were then pelleted at 100,000 g for 1.5 h and washed with 1 M so-
dium carbonate, and the pellets were resuspended in 8 M urea. 250 µg 
protein was digested using the filter-aided sample preparation protocol, and 
the resulting tryptic peptides were fractionated using high-pH reversed-phase 
HPLC. A total of 53 fractions were analyzed using a mass spectrometer 
(Orbitrap XL; Thermo Fisher Scientific) coupled to a nanoAcquity HPLC 
(Waters). Peptides were resolved using a 25-cm ethylene bridged hybrid col-
umn with a gradient rising from 3 to 25% MeCN over 30 min, 45% MeCN 
by 45 min, and 85% MeCN by 50 min. Eluting peptides were subjected to 
mass spectrometry between a 300 and 2,000 mass per charge at 60,000 
full width at half-maximum resolution. Peptides were selected for collision-
induced dissociation fragmentation using a Top6 data-dependent acquisi-
tion with fragmented peptides excluded for 3 min.
Data were processed using MaxQuant v.1.3.0.5 against the UniProt 
Human database (downloaded October 16, 2013). Carbamidomethyl (C) 
was defined as a fixed modification with acetylation (protein N terminus), and 
deamidation (NQ) and oxidation (M) were defined as potential variable 
modifications. Requant was turned on, and a minimum ratio count of 1 was 
required for quantitation, but reported proteins needed to be quantified in 
both the forward and reverse experiment. Postprocessing data manipula-
tion was performed in Perseus v.1.4.0.0.
RNA sequence analysis
Total RNA was harvested from three biological replicates of nonconfluent 
HCT116 (SPP+/+) and B4 (SPP/) cells (RNeasy kit; QIAGEN). RNA integ-
rity was verified on a 2100 Bioanalyzer (Agilent Technologies) before pre-
paring cDNA libraries using a RNA kit (TruSeq; Illumina). Libraries were 
sequenced on a HiSeq platform (Illumina). Reads were aligned to the human 
genome using CLC Genomics Workbench (QIAGEN), and RNA-Seq analy-
sis of the mapped reads was performed using Avadis NGS (Strand Scien-
tific). Differentially expressed genes were identified by the fold change 
method using a Benjamin–Hochberg’s false discovery rate of P < 1 × 104.
Plasmid constructs
The lentiviral expression plasmids are based on a pHR vector obtained from 
A. Thrasher (Center for Immunodeficiency, Institute of Child Health, Univer-
sity College London, London, England, UK; Demaison et al., 2002) and 
were gifts from Y. Ikeda (Mayo Clinic, Rochester, MN). A plasmid express-
ing the envelope protein from vesicular stomatitis virus (pMD-G) and the len-
tiviral packaging plasmid pCMVR8.91 were used in conjunction with the 
lentiviral expression plasmids to produce self-inactivating lentiviral particles 
for transduction. The SPP-expressing lentiviral plasmids pHRSIN SPPwt myc 
KKEK (WT SPP) and pHRSIN SPP D256A myc KKEK (D/A SPP) were sub-
cloned from plasmids pRK SPPwt myc KKEK and pRK SPP D265A myc KKEK 
(gifts from B. Dobberstein, German Cancer Research Center and the Center 
for Molecular Biology of the University of Heidelberg Alliance, Heidelberg, 
Germany; Schrul et al., 2010). The core-expressing lentiviral plasmids 
pHRSIN CMVp core-WT and pHRSIN CMVp core-F130E express hepatitis 
C virus core plus part of E1 and were subcloned from the RNA expression 
plasmids pSFV1 core-E1E2 and pSFV1 core-F130E (gifts from J. McLauchlan; 
Boulant et al., 2006). HA-US2 and HA-US11 were subcloned into a lenti-
viral vector that coexpresses the puromycin (puro) resistance gene 
(pHRSINpgkPURO). pHRSIN HA–HO-1 puro (HA–HO-1) and pHRSIN HO-
1–HA puro (HO-1–HA) were generated by subcloning WT HO-1 from 
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